Action of selective estrogen receptor modulators (SERMs) through the classical mechanism of estrogen action

Selective Estrogen Receptor Modulators: A New Brand of Multitarget Drugs

Volumn , Issue , 2006, Pages 71-77

  Marín, Fernando ^a   Barbancho, Ma Carmen ^b  

^a ELI LILLY AND COMPANY   (United States)

^b HOSPITAL UNIVERSITARIO SANTA CRISTINA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892860610     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/3-540-34742-9_3     Document Type: Chapter

References (22)

1. Abdelrahim M, Samudio I, Smith R, Burghart R, Safe S (2002) Small inhibitory RNA duplexes for Sp! MRNA block basal and estrogen-induced gene expression and cell cycle progression in MCF-7 breast cancer cells. J Biol Chem 77:28815-28822
2. Brzozowski AM, Pike A C W, Dauter Z, Hubbard RE, Bonn T, Engström O, et al. (1997) Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 89:753-758
3. Ho KJ, Liao JK (2002) Non-nuclear actions of estrogen. Arterioscler Throm Vas Biol 2:1952-1961
4. Kousteni S, Han L, Chen JR, Almeida M, Plotkin LI, Bellido T, Manolagas SC (2003) Kinase-mediated regulation of common transcription factors accounts for the boneprotective effects of sex steroids. J Clin Invest 11:1651-1664
5. Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson JA (1997) Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 38:863-870
6. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA (1996) Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 3:5925-5930
7. Kushner PJ, Agard DA, Greene GL, Scanlan TS, Shiau AK, Uth R, et al. (2000) Estrogen receptor pathways to AP-1. J Steroid Biochem Mol Biol 74:311-317
8. McDonnell DP, Wijayarate A, Chang C, Norris JD (2002) Elucidation of the molecular mechanism of action of selective estrogen receptor modulators. Am J Cardiol 0(Suppl):35F-43F
9. Meegan MJ, Lloyd DG (2003) Advances in the science of estrogen receptor modulation. Curr Med Chem 0:181-210
10. Paech K, Webb P, Kuiper G G J M, Nilsson S, Gustafsson JA, Kushner PJ, et al. (1997) Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites. Science 77:1508-1510
11. Qui J, Bosch MA, Tobias SC, Grandy DK, Scanlan TS, Ronnekleiv OK, et al. (2003) Rapid signaling of estrogen in hypothalamic neurons involves a novel G-protein-coupled estrogen receptor that activates protein kinase C. J Neurosci 3:9529-9540
12. Rosenfeld MG, Glass CK (2001) Coregulator codes of transcriptional regulation by nuclear receptors. J Biol Chem 276:36865-36868
13. Salom JB, Burguete MC, Pérez-Asensio FJ, Centeno JM, Torregrosa G, Alborch E (2002) Acure relaxant effects of 17-β-estradiol through non-genomic mechanisms in rabbit carotid artery. Steroids 7:339-346
14. Shang Y, Brown M (2002) Molecular determinants for the tissue specificity of SERMs. Science 295:2465-2468
15. Shiau AK, Barstad D, Loria PM, Cheng L, Kushner PJ, Agard A, Greene GL (1998) The structural basis of estrogen receptor/co-activator recognition and the antagonism of this interaction with tamoxifen. Cell 5:927-937
16. Simoncini T, Genazzani AR, Liao JK (2002a) Nongenomic mechanisms of endothelial nitric oxide synthetase activation by the selective estrogen receptor modulator raloxifene. Circulation 105:1368-1373
17. Simoncini T, Varone G, Fornari L, Mannella P, Luisi M, Labrie F, et al (2002b) Genomic and nongenomic mechanisms of nitric oxide synthesis induction in human endothelial cells by a fourth-generation selective estrogen receptor modulator. Endocrinology 43:2052-2061
18. Smith CL, O'Malley BW (2004) Co-regulator function: a key to understanding tissue specificity of selective receptor modulators. Endocr Rev 25:45-71
19. Wassmann S, Laufs U, Stamenkovic D, Linz W, Stasch JP, Ahlbory K, Rosen R, Bohm M, Nickening G (2002) Raloxifene improves endothelial dysfunction in hypertension by reduced oxidative stress and enhanced nitric oxide production. Circulation 105:2083-2091
20. Yang NN, Bryant HU, Hardikar S, Sato M, Galvin R J S, Glasebrook AL, et al. (1996a) Estrogen and raloxifene stimulate transforming growth factor-β3 expression in rat bone: a potent mechanism for estrogen- or raloxifene-mediated bone maintenance. Endocrinology 37:2075-2084
21. Yang NN, Venugopalan M, Hardikar S, Glasebrook AL (1996b) Identification of an estrogen response element activated by metabolites of 17-β-estradiol and raloxifene. Science 73:1222-1225.
22. [Letter. Published errata: Science 275:1249, 1997 Feb. 28]